Understanding lipid nanoparticles (LNPs)

Five pioneers of LNP characterization share their lesson learned

Lipid nanoparticles (LNPs) hold great promise as drug delivery vectors for nucleic acid-based drugs and vaccines. However, they pose significant manufacturing and analytical challenges due to their intrinsic structural complexity.

Join us for a lively and interactive online panel discussion, as our experts consider the physical properties of these complex particles and consider the application of analytical techniques in the development of LNPs as drug delivery vectors. Our special guests, Fanny Caputo from LNE and Jérémie Parot from SINTEF, will share their insights and research. They’ll be joined by our inhouse technical experts, who will provide a perspective on the tools and strategies you need to succeed.

Join us to find out:

  • How leading researchers are using analytics as a competitive advantage
  • Tools and strategies to optimize your samples
  • Which established analytical techniques are being increasingly implemented by biotech organizations
  • Real-world examples that demonstrate best practice
  • Answers to your questions and help to overcome your challenges

Meet the panel:

  • Dr Fanny Caputo, Research Engineer, Laboratoire National De Métrologie Et D'essais
  • Dr Jérémie Parot, Research Scientist, SINTEF
  • Dr Natalia Markova, Segment Marketing Manager, Malvern Panalytical
  • Dr Hanna Jankevics-Jones, Segment Marketing Manager, Malvern Panalytical
  • Dr Stefan Cairns, Product Technical Specialist (Separations), Malvern Panalytical

To accelerate your analytics, learn more about lipid nanoparticle characterization with Malvern Panalytical here: Gene Therapy and Vaccines.

This is the final session our six-part “Vector Analytics Masterclass” series. Discover more in our Vector Analytics webinar hub.

Speakers

  • Dr Fanny Caputo, Research Engineer, Laboratoire National De Métrologie Et D'essais
  • Dr Jérémie Parot, Research Scientist, SINTEF
  • Dr Natalia Markova, Segment Marketing Manager, Malvern Panalytical
  • Dr Hanna Jankevics-Jones, Segment Marketing Manager, Malvern Panalytical
  • Dr Stefan Cairns, Product Technical Specialist (Separations), Malvern Panalytical

More information

Who should attend? 

Scientists and project leaders working on the design, process and formulation development of viral and non-viral delivery vectors, such as viral particles, lipid nanoparticles (LNPs) and liposomes for drug and vaccine delivery. 

What will you learn? 

  • Learn about the physical properties of lipid nanoparticles (LNPs)
  • Understand which analytical technologies assist with LNP vector characterization and understand what the techniques can tell you about your LNP sample
  • Learn how to analyze specific characteristics of lipid nanoparticles
  • Learn about the importance of applying orthogonal techniques
  • Understand the strengths and weaknesses of various characterization techniques